Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism CTHRC1 inhibitors(collagen triple helix repeat containing 1 inhibitors), FN1 inhibitors(Fibronectin inhibitors), Smad proteins inhibitors(Smad proteins inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Idiopathic Pulmonary Fibrosis | Preclinical | United States | 17 Mar 2026 |





